Etoricoxib-d4

• CAT Number: S000069
• CAS Number: 1131345-14-6
• Molecular Formula: C18H11D4ClN2O2S
• Molecular Weight: 362.87
• Purity: ≥95%
• Target: COX
• IUPAC Name: 5-chloro-2-(6-methylpyridin-3-yl)-3-(2,3,5,6-tetradeuterio-4-methylsulfonylphenyl)pyridine
• InChI: InChI=1S/C18H15ClN2O2S/c1-12-3-4-14(10-20-12)18-17(9-15(19)11-21-18)13-5-7-16(8-6-13)24(2,22)23/h3-11H,1-2H3/i5D,6D,7D,8D
• InChIKey: MNJVRJDLRVPLFE-KDWZCNHSSA-N
• SMILES: [2H]C1=C(C(=C(C(=C1C2=C(N=CC(=C2)Cl)C3=CN=C(C=C3)C)[2H])[2H])S(=O)(=O)C)[2H]

Etoricoxib-d4 (CAS 1131345-14-6) is a high-purity deuterated compound used in advanced pharmaceutical research. This isotopically labeled version of Etoricoxib is essential for studies involving COX-2 inhibitors, pharmacokinetics, and metabolic pathways. Featuring four deuterium atoms, it ensures precise and reliable analytical results. Its advanced formulation provides enhanced stability and consistency, making it suitable for various experimental setups. Ideal for anti-inflammatory drug research and development, Etoricoxib-d4 integrates seamlessly into existing protocols, offering a robust and cost-effective solution for high-precision scientific investigations.